Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

taseen trading sdn bhd - enrofloxacin -

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

enrofloxacin 100mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

enrofloxacin 100mg/ml

Israel - English - Ministry of Health

a.l. medi-market ltd. - enrofloxacin - solution for injection - enrofloxacin 50 mg / 1 ml - in calves:treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of pasteurella multocida, mannheimia haemolytica and mycoplasma spp. treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of escherichia coli. treatment of septicaemia caused by enrofloxacin susceptible strains of escherichia coli. treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of mycoplasma bovis.only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

United States - English - NLM (National Library of Medicine)

putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - enrofloxacin - infus/pdr/oral soln - 100 mg/ml - enrofloxacin - fowl - chicken, fowl - turkey - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - enrofloxacin - oral solution - 100 milligram(s)/millilitre - enrofloxacin - chickens, turkeys - antibacterial

Spain - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin

Italy - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin

Portugal - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin